Company Profile for DiaKine Therapeutics, Inc.DiaKine Therapeutics is a development-stage company commercializing Lisofylline and related compounds into therapies for diabetes and related complications. The Company was spun out of research into the diabetes treatment applications of LSF LSF Lisofylline, see there conducted by Dr. Jerry L. Nadler, Chief of Endocrinology and Metabolism at the University of Virginia School of Medicine University of Virginia School of Medicine is a medical school located in Charlottesville, Virginia, United States. History Thomas Jefferson founded the University of Virginia in 1819. . Initial therapies being developed by DiaKine are an adjunct to improve the outcomes of islet cell islet cell n. One of the endocrine cells making up the islets of Langerhans. transplants and to halt the progression of Type-1 diabetes in newly-diagnosed adults. Future applications include treatment for diabetes complications and Latent Autoimmune Disease autoimmune disease, any of a number of abnormal conditions caused when the body produces antibodies to its own substances. In rheumatoid arthritis, a group of antibody molecules called collectively RF, or rheumatoid factor, is complexed to the individual's own gamma of Adults (LADA LADA Larga Distancia (Spanish: Long distance telephone services) LADA Langkawi Development Authority (Malaysia) LADA Laser-Assisted Device Alteration LADA Light Air Defense Artillery ) diabetes.
Company: DiaKine Therapeutics, Inc.
Headquarters Address: 1414 Sachem Place
Suite 3
Charlottesville, VA 22901
Main Telephone: 434-975-2001
Website: www.diakine.com
Type of Organization: Private
Industry: Health: Pharmaceutical
Key Executives: CEO: Keith Ignotz
Chairman: Jerry Nadler, M.D.
Public Relations
Contact: Bill Wells
Phone: 404-281-7490
Email: wells100@ix.netcom.com
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion